JP2011521966A5 - - Google Patents

Download PDF

Info

Publication number
JP2011521966A5
JP2011521966A5 JP2011511828A JP2011511828A JP2011521966A5 JP 2011521966 A5 JP2011521966 A5 JP 2011521966A5 JP 2011511828 A JP2011511828 A JP 2011511828A JP 2011511828 A JP2011511828 A JP 2011511828A JP 2011521966 A5 JP2011521966 A5 JP 2011521966A5
Authority
JP
Japan
Prior art keywords
mab
seq
humanized
sequence
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011511828A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011521966A (ja
JP5972573B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/045519 external-priority patent/WO2009148928A1/en
Publication of JP2011521966A publication Critical patent/JP2011521966A/ja
Publication of JP2011521966A5 publication Critical patent/JP2011521966A5/ja
Application granted granted Critical
Publication of JP5972573B2 publication Critical patent/JP5972573B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011511828A 2008-05-29 2009-05-28 塩基性線維芽細胞成長因子に対するモノクローナル抗体 Expired - Fee Related JP5972573B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US5718308P 2008-05-29 2008-05-29
US61/057,183 2008-05-29
US17056109P 2009-04-17 2009-04-17
US61/170,561 2009-04-17
PCT/US2009/045519 WO2009148928A1 (en) 2008-05-29 2009-05-28 Monoclonal antibodies to basic fibroblast growth factor

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015094533A Division JP2016006034A (ja) 2008-05-29 2015-05-06 塩基性線維芽細胞成長因子に対するモノクローナル抗体

Publications (3)

Publication Number Publication Date
JP2011521966A JP2011521966A (ja) 2011-07-28
JP2011521966A5 true JP2011521966A5 (cg-RX-API-DMAC7.html) 2012-06-14
JP5972573B2 JP5972573B2 (ja) 2016-08-17

Family

ID=41398450

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2011511828A Expired - Fee Related JP5972573B2 (ja) 2008-05-29 2009-05-28 塩基性線維芽細胞成長因子に対するモノクローナル抗体
JP2015094533A Pending JP2016006034A (ja) 2008-05-29 2015-05-06 塩基性線維芽細胞成長因子に対するモノクローナル抗体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015094533A Pending JP2016006034A (ja) 2008-05-29 2015-05-06 塩基性線維芽細胞成長因子に対するモノクローナル抗体

Country Status (11)

Country Link
US (2) US8101725B2 (cg-RX-API-DMAC7.html)
EP (1) EP2288717B1 (cg-RX-API-DMAC7.html)
JP (2) JP5972573B2 (cg-RX-API-DMAC7.html)
KR (1) KR101590495B1 (cg-RX-API-DMAC7.html)
CN (1) CN102046803B (cg-RX-API-DMAC7.html)
AU (1) AU2009255305B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0912035A2 (cg-RX-API-DMAC7.html)
CA (1) CA2725873C (cg-RX-API-DMAC7.html)
ES (1) ES2633297T3 (cg-RX-API-DMAC7.html)
MX (1) MX2010012616A (cg-RX-API-DMAC7.html)
WO (1) WO2009148928A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101590495B1 (ko) 2008-05-29 2016-02-01 갤럭시 바이오테크, 엘엘씨 염기성 섬유모세포 성장 인자에 대한 모노클로날 항체
WO2013134414A1 (en) * 2012-03-06 2013-09-12 Galaxy Biotech, Llc Bispecific antibodies with an fgf2 binding domain
JP2016510751A (ja) 2013-03-06 2016-04-11 ジェネンテック, インコーポレイテッド 抗がん剤耐性を治療及び予防する方法
US9415118B2 (en) 2013-03-13 2016-08-16 Novartis Ag Antibody drug conjugates
US9498532B2 (en) * 2013-03-13 2016-11-22 Novartis Ag Antibody drug conjugates
WO2015191986A1 (en) 2014-06-13 2015-12-17 Genentech, Inc. Methods of treating and preventing cancer drug resistance
CN104231079A (zh) * 2014-09-12 2014-12-24 暨南大学 一种靶向bFGF高亲和力受体结合位点的抗体及其应用
PL238516B1 (pl) 2016-06-13 2021-08-30 Univ Wroclawski Sposób otrzymywania modyfikowanego polipeptydu
IL266769B2 (en) * 2016-11-22 2024-04-01 Merck Patent Gmbh Monoclonal antibodies specific for fgfr1 and their preparation
TW202229343A (zh) 2020-08-21 2022-08-01 美商健臻公司 Fgfr3抗體及使用方法
CN115869397B (zh) * 2022-08-31 2026-03-20 暨南大学 Fgf-2纳米抗体在制备治疗银屑病药物中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3101690B2 (ja) 1987-03-18 2000-10-23 エス・ビィ・2・インコーポレイテッド 変性抗体の、または変性抗体に関する改良
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
AU6605690A (en) 1989-10-27 1991-05-31 Du Pont Merck Pharmaceutical Company, The Monoclonal antibodies to basic fibroblast growth factor that inhibit its biological activity
EP1690935A3 (en) 1990-01-12 2008-07-30 Abgenix, Inc. Generation of xenogeneic antibodies
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
ES2139598T3 (es) 1990-07-10 2000-02-16 Medical Res Council Procedimientos para la produccion de miembros de parejas de union especifica.
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
JPH07503132A (ja) 1991-12-17 1995-04-06 ジェンファーム インターナショナル,インコーポレイティド 異種抗体を産生することができるトランスジェニック非ヒト動物
US5834597A (en) 1996-05-20 1998-11-10 Protein Design Labs, Inc. Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
WO2000046380A2 (en) * 1999-02-08 2000-08-10 Chiron Corporation Fibroblast growth factor receptor-immunoglobulin fusion
IL139380A0 (en) * 2000-10-31 2001-11-25 Prochon Biotech Ltd Active variants of fibroblast growth factor
EP1476120B1 (en) * 2002-02-21 2010-09-29 Duke University Treatment methods using anti-cd22 antibodies
US7220410B2 (en) 2003-04-18 2007-05-22 Galaxy Biotech, Llc Monoclonal antibodies to hepatocyte growth factor
US7560244B2 (en) * 2003-06-04 2009-07-14 Joslin Diabetes Center, Inc. Method of evaluating a subject for risk or predisposition of reduced renal function over time
EA015363B1 (ru) 2003-07-18 2011-06-30 Эмджен Инк. Агенты, специфически связывающие фактор роста гепатоцитов, и их применение
JP3904578B2 (ja) 2005-04-08 2007-04-11 シャープ株式会社 半導体装置の製造方法
RU2007146986A (ru) * 2005-06-02 2009-06-27 ГЭЛЭКСИ БАЙОТЕК, ЭлЭлСи (US) Способы лечения опухолей головного мозга с использованием антител
AR059922A1 (es) 2006-04-01 2008-05-07 Galaxy Biotech Llc Anticuerpos monoclonales humanizados para el factor de crecimiento de hepatocitos
US7649083B2 (en) 2006-06-02 2010-01-19 Aveo Pharmaceuticals, Inc. Hepatocyte growth factor (HGF) binding antibody
MX2008015138A (es) 2006-06-02 2009-01-28 Aveo Pharmaceuticals Inc Proteinas de union al factor de crecimiento de hepatocitos (fch).
KR101590495B1 (ko) 2008-05-29 2016-02-01 갤럭시 바이오테크, 엘엘씨 염기성 섬유모세포 성장 인자에 대한 모노클로날 항체

Similar Documents

Publication Publication Date Title
RU2011141890A (ru) Моноклональные антитела к рецептору 2 фактора роста фибробластов
AU2013327116B2 (en) Combination of anti-KIR antibodies and anti-PD-1 antibodies to treat cancer
RU2018100424A (ru) Комбинированная терапия для лечения злокачественной опухоли
JP2018534933A5 (cg-RX-API-DMAC7.html)
JP2009532378A5 (cg-RX-API-DMAC7.html)
RU2018114904A (ru) Антитело против garp
JP2009521496A5 (cg-RX-API-DMAC7.html)
JP2019532619A5 (cg-RX-API-DMAC7.html)
JP2011514150A5 (cg-RX-API-DMAC7.html)
ME02371B (me) Sastojci i postupci za dijagnstikovanje i tretman raka
JP2021524268A5 (cg-RX-API-DMAC7.html)
RU2008143318A (ru) Гуманизированные моноклональные антитела к фактору роста гепатоцитов
JP2018506277A5 (cg-RX-API-DMAC7.html)
JP2017149720A5 (cg-RX-API-DMAC7.html)
JP2012530496A5 (cg-RX-API-DMAC7.html)
JP2015525795A5 (cg-RX-API-DMAC7.html)
JP2014158469A5 (cg-RX-API-DMAC7.html)
HRP20150965T1 (hr) Anti-fgr3 protutijela i metode koje ih koriste
JP2010526028A5 (cg-RX-API-DMAC7.html)
JP2020514310A5 (cg-RX-API-DMAC7.html)
JP2016512551A5 (cg-RX-API-DMAC7.html)
JP2011046732A5 (cg-RX-API-DMAC7.html)
RU2006140257A (ru) Моноклональные антитела к фактору роста гепатоцитов
JP2015509947A5 (cg-RX-API-DMAC7.html)
JP2017529838A5 (cg-RX-API-DMAC7.html)